Evidence map›Paper›PMID 34396872›Full record

ArticleInhalation toxicology

A novel sulfur mustard (HD) vapor inhalation exposure model of pulmonary toxicity for the efficacy evaluation of candidate medical countermeasures.

Mark R Perry, Matthew Neal, Roger Hawks, David Pressburger, Jan Satola, Cheryl Triplett, Beth Reed, Meredith Andrews, Jill A Harvilchuck, Michael S Nealy and 2 more

Open access · greenAbstract read
In one paragraph

Article in Inhalation toxicology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mark R PerryAmplifyBio, West Jefferson, OH, USA.
Matthew NealBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Roger HawksBiomedical Research Center, Battelle, West Jefferson, OH, USA.
David PressburgerBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Jan SatolaBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Cheryl TriplettBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Beth ReedBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Meredith AndrewsBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Jill A HarvilchuckBiomedical Research Center, Battelle, West Jefferson, OH, USA.
Michael S NealyNational Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Gennady E PlatoffNational Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
David T YeungNational Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Battelle · USNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

Intramural NIH HHS Z99 AI999999
6 · The paper itself

Abstract

objectiveTo develop a novel inhalation exposure system capable of delivering a controlled inhaled HD dose through an endotracheal tube to anesthetized rats to investigate the lung pathophysiology and evaluate potential medical countermeasures. MATERIALS AND

methodsTarget HD vapor exposures were generated by a temperature-controlled vapor generator, while concentration was monitored near real-time by gas chromatography. Animal breathing parameters were monitored real-time by in-line EMKA/SciReq pulmonary analysis system. Individual exposures were halted when the target inhaled doses were achieved. Animals were observed daily for clinical observations and lethality with scheduled termination at 28 days post-exposure. Upon scheduled or unscheduled death, animals underwent a gross necropsy and lung and trachea were collected for histopathology.

resultsControlled HD concentrations ranged from 60 to 320 mg/m DISCUSSION/

conclusionThis novel exposure system administers targeted HD inhaled doses to generate a small animal model that can be used to evaluate physiological toxicities of inhaled HD on the lungs and for evaluation of potential medical countermeasure treatments.

Indexed as

Medical CountermeasuresAnimalsDisease Models, AnimalInhalation ExposureLung DiseasesMaleMustard GasRatsRats, Sprague-DawleyMustard Gasinhalation exposureinhaled doselethalitymethodsRatssulfur mustard vapor

Identifiers

PMID34396872
PMCPMC8602763
OpenAlexW3196201110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.